Using Hyperthermia to Augment Drug Delivery - Physics of Thermal Therapy - page 288

Gaber, M. H., Wu, N. Z., Hong, K., Huang, S. K., Dewhirst,
M. W., Papahadjopoulos, D. 1996 Thermosensitive lipo-
somes: Extravasation and release of contents in tumor
microvascular networks. Int J Radiat Oncol Biol Phys , 36:
1177-87.
Gabizon, A., Shmeeda, H., Barenholz, Y. 2003 Pharmacokinetics
of pegylated liposomal doxorubicin: Review of animal and
human studies. Clinical Pharmacokinetics , 42: 419-36.
Gasselhuber, A., Dreher, M. R., Negussie, A., Wood, B. J., Rattay,
F., Haemmerich, D. 2010 Mathematical spatio-temporal
model of drug delivery from low temperature sensitive
liposomes during radiofrequency tumour ablation. Int J
Hyperthermia , 26: 499-513.
Grenader, T., Goldberg, A., Gabizon, A. 2010 Monitoring long-
term treatment with pegylated liposomal doxorubicin:
How important is intensive cardiac follow-up? Anti-Cancer
Drugs , 21: 868-71.
Gupta, V. K., Jaskowiak, N. T., Beckett, M. A., Mauceri, H. J.,
Grunstein, J., Johnson, R. S. et al. 2002 Vascular endothelial
growth factor enhances endothelial cell survival and tumor
radioresistance. Cancer J , 8: 47-54.
Hahn, G. M., Braun, J., Har-Kedar, I. 1975 hermochemotherapy:
Synergism between hyperthermia (42-43 degrees) and
adriamycin (of bleomycin) in mammalian cell inactivation.
Proc Natl Acad Sci USA , 72: 937-40.
Hauck, M. L., LaRue, S. M., Petros, W. P., Poulson, J. M., Yu,
D., Spasojevic, I. et al. 2006 Phase I trial of doxorubicin-
containing low temperature sensitive liposomes in spontane-
ous canine tumors. Clin Cancer Res , 12: 4004-10.
Herman, T. S., Teicher, B. A. 1994 Summary of studies adding sys-
temic chemotherapy to local hyperthermia and radiation.
Int J Hyperthermia , 10: 443-9.
Herr, H. W., Laudone, V. P., Badalament, R. A., Oettgen, H. F.,
Sogani, P. C., Freedman, B. D. et al. 1988 Bacillus Calmette-
Guerin therapy alters the progression of superficial bladder
cancer. J Clin Oncol , 6: 1450-5.
Herr, H. W., Schwalb, D. M., Zhang, Z. F., Sogani, P. C., Fair, W. R.,
Whitmore, W. F. et al. 1995 Intravesical bacillus Calmette-
Guerin therapy prevents tumor progression and death from
superficial bladder cancer: Ten-year follow-up of a prospective
randomized trial. J Clin Oncol , 13: 1404-8.
Hong, Y. J., Kim, J. C. 2011 Egg phosphatidylcholine liposomes
incorporating hydrophobically modified chitosan: pH-Sen-
sitive release. Journal of Nanoscience and Nanotechnology ,
11: 204-09.
Hossann, M., Wiggenhorn, M., Schwerdt, A., Wachholz, K.,
Teichert, N., Eibl, H. et al. 2007 In vitro stability and content
release properties of phosphatidylglyceroglycerol contain-
ing thermosensitive liposomes. Biochim Biophys Acta , 1768:
2491-9.
Issels, R. D., Lindner, L. H., Verweij, J., Wust, P., Reichardt, P.,
Schem, B. C. et al. 2010 Neo-adjuvant chemotherapy alone
or with regional hyperthermia for localised high-risk soft-
tissue sarcoma: A randomised phase 3 multicentre study.
Lancet Oncol , 11: 561-70.

Jones, E. L., Oleson, J. R., Prosnitz, L. R., Samulski, T. V.,
Vujaskovic, Z., Yu, D. et al. 2005 Randomized trial of hyper-
thermia and radiation for superficial tumors. J Clin Oncol ,
23: 3079-85.
Khan, S. N., Islam, B., Yennamalli, R., Zia, Q., Subbarao, N., Khan,
A. U. 2008 Characterization of doxorubicin binding site and
drug induced alteration in the functionally important struc-
tural state of oxyhemoglobin. Journal of Pharmaceutical and
Biomedical Analysis , 48: 1096-104.
Kleiter, M. M., Yu, D., Mohammadian, L. A., Niehaus, N.,
Spasojevic, I., Sanders, L. et al. 2006 A tracer dose of
technetium-99m-labeled liposomes can estimate the effect
of hyperthermia on intratumoral doxil extravasation. Clin
Cancer Res , 12: 6800-7.
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin,
O. M., Needham, D. et al. 2000 Efficacy of liposomes
and hyperthermia in a human tumor xenograft model:
Importance of triggered drug release. Cancer Res , 60:
6950-7.
Kong, G., Braun, R., Dewhirst, M. 2001 Characterization of the
effect of hyperthermia on nanoparticle extravasation from
tumor vasculature. Cancer Res , 61: 3027-32.
Kong, G., Braun, R. D., Dewhirst, M. W. 2000 Hyperthermia
enables tumor-specific nanoparticle delivery: Effect of par-
ticle size. Cancer Res , 60: 4440-5.
Kong, G., Dewhirst, M. W. 1999 Hyperthermia and liposomes. Int
J Hyperthermia , 15: 345-70.
Koning, G. A., Eggermont, A. M., Lindner, L. H., ten Hagen, T.
L. 2010 Hyperthermia and thermosensitive liposomes for
improved delivery of chemotherapeutic drugs to solid
tumors. Pharm Res , 27: 1750-4.
Landon, C., Park, J. Y., Needham, D., Dewhirst, M. W. 2011
Hyperthermia and nanoscale drug delivery: The mate-
rials design and preclinical and clinical testing of low
temperature-sensitive liposomes used in combination with
mild hyperthermia in the treatment of local cancer. Open
Nanomedicine Journal , 3: 38-64.
Li, L., ten Hagen, T. L., Schipper, D., Wijnberg, T. M., van
Rhoon, G. C., Eggermont, A. M. et al. 2010 Triggered
content release from optimized stealth thermosensitive
liposomes using mild hyperthermia. J Control Release ,
143: 274-9.
Li, L. W., Wang, D. D., Sun, D. Z., Liu, M., Qu, X. K. 2007
Thermodynamic study on interaction between anti-tumor
drug 5-fluorouracil and human serum albumin. Acta
Chimica Sinica , 65: 2853-57.
Lindner, L. H., Eichhorn, M. E., Eibl, H., , Eibl, H., Teichert, N.,
Schmitt-Sody, M. et al. 2004 Novel temperature-sensitive
liposomes with prolonged circulation time. Clin Cancer Res ,
10: 2168-78.
Lindner, L. H., Hossann, M. 2010 Factors affecting drug release from
liposomes. Curr Opin Drug Discov Devel , 13: 111-23.
Lindner, L. H., Reinl, H. M., Schlemmer, M., Stahl, R., Peller,
M. 2005 Paramagnetic thermosensitive liposomes for
MR-thermometry. Int J Hyperthermia , 21: 575-88.